𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapeutic human papillomavirus DNA vaccination strategies to control cervical cancer

✍ Scribed by T.-C. Wu

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
167 KB
Volume
37
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-risk human papillomavirus DNA load
High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer
✍ Albertus T. Hesselink; Johannes Berkhof; Daniëlle A.M. Heideman; Nicole W.J. Bul 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 137 KB 👁 2 views

## Abstract In a population‐based cervical screening cohort, we determined the value of type‐specific viral load assessment for the detection of high‐grade cervical intraepithelial neoplasia and cervical cancer (≥CIN2). Viral load was determined by type‐specific real‐time PCR in women with single H

Case-control study in a subtropical Aust
Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs
✍ Ingeborg L.A. Boxman; Anne Russell; Linda H.C. Mulder; Jan Nico Bouwes Bavinck; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 50 KB 👁 3 views

Epidermodysplasia verruciformis human papillomavirus (EV-HPV) DNA has been demonstrated in malignant and benign skin lesions and in hairs plucked from renal transplant recipients and immunocompetent patients. We investigated the association between EV-HPV DNA in hairs plucked from eyebrows and the o

Occurrence of antibodies TO L1, L2, E4 a
Occurrence of antibodies TO L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controls
✍ Heinrich G. Köchel; Masyar Monazahian; Kai Sievert; Michaela Höhne; Christoph Th 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 820 KB

Sera from I 18 women of 33 to over 90 years of age, with or without a history of cervical squamous-cell carcinoma, were examined for the presence of antibodies to HPV-6b, HPV-I6 and HPV-18 LI, U, E4, and E7 gene products by the use of bacterially derived P-Gal fusion proteins and Western-blot analys